Imel Biotherapeutics develops cell-based therapies to treat patients with mitochondrial disorders. It uses a proprietary mitochondrial replaced cells technology, helping physicians to treat multiple patients with mitochondrial genetic or age-related disorders.The company was founded in 2019 and is based in Waltham, Massachusetts.

Biotechnology

Health Care

Imel Biotherapeutics Inc

Imel Biotherapeutics Inc's headquarters in Waltham, MA, United States

Description

People

Jobs